Travena Inc. (NASDAQ:TRVN) Stock Takes a Hit After Earnings: Time to Sell?

August 13, 2021

Travena Inc. (NASDAQ:TRVN) fell 10% after announcing its Q2 2021 financial results for the period ending June 30, 2021, and also provided an update of recent operations. CEO Carrie Bourdow said that, after barely five months in the sector, the company’s sales team continues to make significant advancements with hospital formularies following the OLINVYK launch. In addition, Bourdow said that the company has commenced rolling out the post-approval clinical trial…

Read More >>